LINTEX
920106
LINGOOD
833284
NTGEC
870436
CG MED EQUIP.
838810
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
600535 Tasly Pharmaceutical Group
- 14.64
- -0.28-1.88%
Market Closed Feb 28 15:00 CST
21.87BMarket Cap22.88P/E (TTM)
15.00High14.60Low94.34KlotVolume14.91Open14.92Pre Close139.45MTurnover0.63%Turnover Ratio22.88P/E (Static)1.49BShares17.4452wk High1.84P/B21.87BFloat Cap11.9152wk Low16.41Limit Up1.49BShs Float38.06Historical High13.43Limit Down2.68%Amplitude-3.05Historical Low0.66Dividend TTM14.78Avg Price42.84KlotAsk4.51%Div YieldTTM100Lot Size49.18KlotBid
Tasly Pharmaceutical Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -32.74%2.99B | -15.83%3.64B | 18.86%4.46B | 33.58%4.36B | 42.68%4.45B | 138.42%4.32B | 75.90%3.75B | 35.29%3.26B | 35.39%3.12B | -12.10%1.81B |
| Transactional financial assets | 74.49%524.72M | 2,010.22%1.33B | 336.87%1.34B | -58.23%498.61M | -73.27%300.71M | -96.05%63.13M | -65.32%305.85M | 10.88%1.19B | -24.37%1.12B | 537.88%1.6B |
| Notes receivable and accounts receivable | 13.39%780.14M | 6.22%1.04B | 19.97%868.39M | 9.30%836.13M | -23.23%688M | -8.60%979.71M | -32.33%723.86M | -32.32%764.99M | -30.78%896.21M | -20.64%1.07B |
| -Accounts receivable | 13.39%780.14M | 6.22%1.04B | 19.97%868.39M | 9.30%836.13M | -23.23%688M | -8.60%979.71M | -32.33%723.86M | -32.32%764.99M | -30.78%896.21M | -20.64%1.07B |
| Other receivables (including interest and dividends) | 100.68%23.06M | 271.34%86.55M | -59.77%17.86M | 21.17%49.25M | 27.91%11.49M | -75.10%23.31M | -60.85%44.39M | -70.01%40.64M | -5.10%8.98M | -63.81%93.59M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --558.91K |
| -Other receivable | 100.68%23.06M | ---- | -59.77%17.86M | ---- | 27.91%11.49M | ---- | -60.72%44.39M | ---- | -5.10%8.98M | ---- |
| Advance payment | -5.41%62.03M | -7.85%95.27M | -0.43%90.6M | 13.29%113.48M | -16.02%65.57M | -18.90%103.39M | -5.55%90.99M | 16.84%100.17M | 25.34%78.08M | -34.90%127.49M |
| Inventories | -2.05%1.71B | -1.05%1.71B | 8.14%1.82B | 8.72%1.79B | 14.07%1.75B | 1.53%1.73B | 0.19%1.68B | -0.11%1.65B | -1.02%1.53B | 11.38%1.7B |
| Receivable financing | -17.83%1.19B | -47.87%1.16B | -52.20%1.15B | -28.59%1.9B | -41.15%1.44B | -10.38%2.22B | -6.78%2.41B | -2.25%2.66B | -1.98%2.45B | -2.15%2.48B |
| Other current assets | 14.84%29.69M | 104.03%14.02M | -18.10%19.25M | -11.47%23.8M | -47.24%25.85M | -67.54%6.87M | 20.75%23.5M | -55.04%26.89M | 14.73%49M | -64.99%21.17M |
| Total current assets | -16.28%7.31B | -3.96%9.07B | 8.10%9.76B | -1.29%9.57B | -5.70%8.73B | 6.06%9.45B | 5.30%9.03B | 4.61%9.7B | 0.12%9.26B | 8.08%8.91B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -19.80%511.87M | -34.23%481.96M | -25.14%558.57M | -13.82%636M | 31.56%638.22M | 19.97%732.75M | 18.69%746.19M | 21.79%738.02M | -34.93%485.1M | -38.25%610.79M |
| Long-term equity investment | -7.49%1.31B | -11.10%1.37B | -9.62%1.38B | -9.46%1.39B | 37.95%1.42B | 95.70%1.54B | 194.13%1.53B | 215.16%1.54B | 112.18%1.03B | -7.89%786.48M |
| Fixed assets | -4.62%3.23B | ---- | -4.66%3.27B | ---- | -4.80%3.39B | ---- | -3.57%3.43B | ---- | -3.33%3.56B | ---- |
| Constru in process | 44.12%221.76M | ---- | 7.87%197.44M | ---- | 49.44%153.87M | ---- | -9.72%183.03M | ---- | -38.66%102.96M | ---- |
| Intangible assets | 5.32%604.17M | 1.75%596.48M | -23.37%548.05M | 0.34%561.94M | 24.86%573.64M | 29.43%586.24M | 57.34%715.23M | 20.61%560.05M | -3.18%459.43M | 6.08%452.94M |
| Development expenditure | -0.50%1.45B | 8.73%1.54B | 26.17%1.55B | 26.84%1.49B | 28.81%1.45B | 12.05%1.42B | 2.25%1.23B | 0.69%1.17B | -2.00%1.13B | -8.19%1.27B |
| Goodwill | ---- | 0.00%15.88M | 0.00%15.88M | 0.00%15.88M | 0.00%15.88M | -90.50%15.88M | -90.50%15.88M | -90.50%15.88M | -90.50%15.88M | 0.24%167.08M |
| Long deferred expense | -10.98%20.67M | -12.05%15.3M | -12.11%17.34M | -18.69%21.21M | -19.13%23.22M | -35.83%17.4M | -36.16%19.72M | -41.17%26.08M | -32.06%28.72M | -64.89%27.11M |
| Deferred tax assets | 6.34%53.17M | -25.40%39.65M | -11.30%47.46M | -1.29%52.61M | -43.36%50M | -4.40%53.15M | 9.70%53.51M | -29.65%53.3M | 45.24%88.29M | -19.64%55.6M |
| Usufruct assets | -14.26%194.28M | -4.40%192.22M | 1.52%204.44M | 9.09%224.15M | 2.77%226.6M | -0.56%201.07M | -4.76%201.39M | -5.05%205.47M | -7.27%220.48M | 170.10%202.2M |
| Other non current assets | 68.15%72.54M | 20.28%60.14M | 18.98%49.9M | -62.12%37.35M | -57.74%43.14M | -30.14%50M | -38.96%41.94M | 7.95%98.6M | 28.12%102.08M | 2,296.40%71.57M |
| Total non current assets | -3.96%7.67B | -5.67%7.76B | -3.95%7.85B | -1.55%7.94B | 10.60%7.98B | 11.30%8.23B | 15.15%8.17B | 13.52%8.07B | -1.04%7.22B | -6.50%7.39B |
| Total assets | -10.40%14.98B | -4.76%16.83B | 2.37%17.6B | -1.41%17.52B | 1.44%16.71B | 8.44%17.68B | 9.76%17.2B | 8.47%17.77B | -0.39%16.48B | 0.94%16.3B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -3.25%699.54M | -18.25%993.29M | -12.58%823.42M | -29.05%663.37M | 291.95%723.05M | 156.89%1.22B | 187.16%941.89M | 96.41%934.97M | 3.67%184.48M | 166.24%472.99M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40M |
| Notes payable and accounts payable | 5.95%606.81M | 34.98%1.09B | 101.95%1.59B | 47.84%1.25B | -35.49%572.73M | -10.18%809.87M | -9.91%787.77M | -27.95%843.39M | 21.85%887.77M | 39.45%901.66M |
| -Notes payable | 45.87%188.04M | 96.44%621.51M | 392.48%1.09B | 258.18%706.33M | -56.08%128.91M | 13.24%316.39M | -14.47%221.93M | -65.69%197.2M | 48.33%293.52M | 95.80%279.41M |
| -Accounts payable | -5.64%418.77M | -4.41%471.7M | -12.00%497.97M | -16.35%540.57M | -25.31%443.82M | -20.69%493.48M | -7.98%565.84M | 8.45%646.19M | 11.97%594.25M | 23.49%622.25M |
| Contract liabilities | -24.14%67.53M | 9.60%86.17M | 28.90%100.58M | 22.36%93.49M | -3.20%89.02M | 240.87%78.63M | 71.69%78.03M | 30.04%76.4M | 39.29%91.96M | -11.02%23.07M |
| Advance receipts | -0.42%66.08M | 4.04%66.33M | 4.04%66.33M | -11.69%64.02M | 3.46%66.36M | -14.73%63.76M | -10.06%63.76M | 7.78%72.49M | -2.90%64.14M | 13.51%74.77M |
| Salaries payable | -0.61%113.61M | -4.83%86.34M | -17.02%63.79M | -37.77%37.21M | -18.70%114.3M | -18.41%90.73M | -9.59%76.88M | 2.12%59.79M | 13.02%140.6M | 83.83%111.2M |
| Taxs payable | 41.11%120.81M | -2.10%97.39M | -21.89%89.54M | -33.86%106.24M | -55.19%85.61M | -19.53%99.48M | -23.23%114.63M | -14.22%160.63M | -4.72%191.07M | 26.05%123.63M |
| Other payable (including interest and dividends) | -79.19%38.26M | -67.07%60.47M | -65.11%68.32M | -26.98%115.97M | 253.16%183.91M | 170.25%183.62M | 252.35%195.83M | 71.86%158.82M | 8.08%52.07M | -40.65%67.94M |
| -Other payable | -79.19%38.26M | ---- | -65.11%68.32M | ---- | 253.16%183.91M | ---- | 252.35%195.83M | ---- | 8.08%52.07M | ---- |
| Non current liabilities due within one year | 21.75%634.67M | 96.78%875.71M | 43.22%497.12M | 3.68%519.15M | -1.59%521.28M | 17.75%445.01M | -43.68%347.11M | 34.98%500.72M | 32.55%529.69M | 172.68%377.93M |
| Other current liabilities | -82.09%2.38M | -54.47%1.96M | -9.46%3.71M | 669.81%6.44M | 144.68%13.3M | 345.71%4.3M | 141.49%4.1M | -66.27%836.1K | 46.00%5.44M | -67.60%965.14K |
| Total current liabilities | -0.84%2.35B | 12.39%3.36B | 26.58%3.3B | 1.59%2.85B | 10.35%2.37B | 36.29%2.99B | 15.15%2.61B | 11.24%2.81B | 15.75%2.15B | 64.89%2.19B |
| Current liabilities | ||||||||||
| Long term loan | -82.05%253.76M | -85.75%244.36M | -32.00%1.24B | -23.13%1.44B | 2.75%1.41B | 28.16%1.72B | 133.81%1.82B | 119.63%1.87B | 33.04%1.38B | 13.44%1.34B |
| Estimate liabilities | ---- | --1.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 260.29%398.03K | -99.33%110.43K | -99.38%110.43K | -88.42%2.36M | -99.52%110.48K | -22.91%16.55M | -29.71%17.95M | -20.35%20.35M | -45.77%22.87M | -69.78%21.47M |
| Long term deferred income | 21.54%193.29M | -6.64%153.35M | -6.57%154.96M | -9.49%159.97M | -10.56%159.02M | -16.15%164.26M | -18.84%165.87M | -16.46%176.74M | -17.14%177.79M | -7.57%195.89M |
| Lease liabilities | -16.62%67.97M | -15.15%57.11M | 16.57%64.63M | 21.82%85.56M | 8.26%81.52M | 28.50%67.31M | -8.60%55.45M | -8.72%70.23M | -7.75%75.31M | 623.10%52.38M |
| Total non current liabilities | -68.85%515.41M | -76.76%456.35M | -29.23%1.46B | -21.15%1.69B | 0.15%1.65B | 22.09%1.96B | 92.65%2.06B | 83.41%2.14B | 20.35%1.65B | 9.36%1.61B |
| Total liabilities | -28.80%2.87B | -22.94%3.82B | 1.96%4.76B | -8.24%4.54B | 5.92%4.02B | 30.29%4.95B | 39.99%4.67B | 34.05%4.95B | 17.71%3.8B | 35.74%3.8B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.38%1.49B | -0.38%1.49B | -0.38%1.49B | -0.38%1.49B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | -0.55%1.5B | -0.86%1.5B | -0.86%1.5B |
| Capital reserve funds | -52.10%458.96M | -10.61%864.86M | -18.23%863.56M | -35.50%857.85M | -34.22%958.08M | -27.70%967.51M | -21.08%1.06B | -7.30%1.33B | -4.82%1.46B | -42.36%1.34B |
| Surplus reserve funds | 6.52%1.74B | 7.33%1.64B | 7.33%1.64B | 7.33%1.64B | 7.33%1.64B | 7.12%1.53B | 7.12%1.53B | 7.12%1.53B | 7.12%1.53B | 9.87%1.42B |
| Retained profit | -1.65%8.15B | 2.92%8.64B | 4.84%8.46B | 4.55%8.59B | 5.96%8.29B | 5.34%8.4B | 2.20%8.07B | -0.34%8.21B | -11.05%7.83B | -0.96%7.97B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | 0.00%105.98M | 0.00%105.98M | 0.00%105.98M | -41.04%105.98M | -57.82%105.98M | -53.32%105.98M |
| Other composite income | -40.66%52.22M | -41.38%70.34M | -44.67%75.65M | -14.72%82.84M | -58.41%88M | 37.12%119.99M | 820.00%136.73M | 393.48%97.14M | 757.27%211.58M | 381.59%87.51M |
| Shareholders equity without minority interests | -3.76%11.9B | 2.46%12.71B | 2.86%12.53B | 0.79%12.66B | -0.35%12.37B | 1.55%12.4B | 1.23%12.18B | 1.33%12.56B | -4.38%12.41B | -5.47%12.21B |
| Minority interests | -35.36%207.86M | -2.69%310.55M | -9.28%311.9M | 22.17%318.98M | 21.30%321.59M | 12.52%319.14M | 15.81%343.8M | -11.34%261.09M | -20.28%265.12M | -33.44%283.64M |
| Total shareholder equity | -4.56%12.11B | 2.33%13.02B | 2.53%12.84B | 1.23%12.98B | 0.10%12.69B | 1.79%12.72B | 1.59%12.53B | 1.04%12.82B | -4.78%12.68B | -6.36%12.5B |
| Total liabilityies and equity | -10.40%14.98B | -4.76%16.83B | 2.37%17.6B | -1.41%17.52B | 1.44%16.71B | 8.44%17.68B | 9.76%17.2B | 8.47%17.77B | -0.39%16.48B | 0.94%16.3B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
